gil harari statistical considerations in clinical trials
TRANSCRIPT
Analyses Variables
• Primary Efficacy Variables
• Secondary Efficacy Variables
• Safety Variable Adverse Events. Physical examinations. Laboratory measurements . Reasons for discontinuation.
Is risk factor X associated with disease Y?
From the sample, we compute an estimate of the effect of X on Y (e.g., risk ratio if cohort study):
-Is the effect real? Did chance play a role?
Interpreting the results
PopulationSelection of subjects
Inference
Make inferences from data collected using laws of probability and statistics
-tests of significance (p-value) -confidence intervals
How do we determine if an association is significant?
• Significance is in context of “Statistical” significance
– p-Value – Treatment Effect– Confidence Interval
8
Subjects for Discussion
1. What is a p-Value?
2. Sample Size Calculation
3. Clinical Significance Versus Statistical Significance
Basic Principles of Statistical Analysis
Significance Tests
Difference Between Treatments
Is it by chance?
Apply a significance test
Sample Size Calculation
Based on:
1 .Study Design
2 .Treatment Effect (Effect Size) (δ)
3 .Type I error (α), Type II error (β)
4. Power of the study (1-β)
Clinical significance Versus Statistical Significance
CR
TA
%Im
prov
emen
t %Im
prov
emen
t
43%
65%
Clinical Significance Statistical Significance
P=0.17
P=0.03
TBCR
52%
41%
N = 15 N = 60